NU Skin Enterprises Inc
XMUN:NUS

Watchlist Manager
NU Skin Enterprises Inc Logo
NU Skin Enterprises Inc
XMUN:NUS
Watchlist
Price: 4.874 EUR -0.45% Market Closed
Market Cap: €242.3m

NU Skin Enterprises Inc
Investor Relations

NU Skin Enterprises sells personal-care and wellness products under brands such as Nu Skin and Pharmanex. Its products include skincare, beauty devices, nutritional supplements, and other health-focused items. The company reaches customers through a direct-selling model, using independent brand affiliates and distributors who sell the products to end consumers. The company makes money mainly by selling its products through this network, rather than through traditional retail stores. Its distributors earn commissions and other rewards based on product sales, which helps NU Skin build a large sales force without owning a big store chain. That makes the business model different from a standard consumer goods company that depends mostly on supermarkets, drugstores, or online marketplaces. For beginner investors, the key thing to know is that NU Skin sits between a consumer brand and a direct-selling network. It designs and sources the products, then relies on its affiliate system to market and sell them in many countries. That structure can help it build customer loyalty around specific products, but it also means the business depends heavily on distributor engagement and on consumer interest in beauty and wellness products.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
May 7, 2026
AI Summary
Q1 2026

Results in line: Nu Skin said Q1 revenue of $320.6 million and adjusted EPS of $0.14 were in line with guidance, while GAAP EPS was $0.04.

Prysm iO traction: Management said the new Prysm iO platform is gaining early adoption, with nearly 2 million scans, more than 30,000 devices sold, and early signs that subscriptions and higher-value customer behavior are improving.

Emerging markets focus: Latin America and Mainland China showed improvement, while India remains a longer-term opportunity; management said 2026 will be mostly a learning year ahead of a planned formal launch by year-end.

Margins and costs: Gross margin held up, but selling expense and G&A rose as Nu Skin invested in sales leader incentives, technology, and market expansion; the company is still working to improve efficiency.

Outlook unchanged: Full-year guidance was maintained, though management said it is taking a measured approach because macro pressure from tariffs, fuel costs, and geopolitics could affect consumers later in the year.

Key Financials
Revenue
$320.6 million
Earnings per share
$0.04
Adjusted earnings per share
$0.14
Adjusted gross margin
67.9%
Core business gross margin
76.9%
Consolidated selling expense
34.3% of revenue
Core business selling expense
40.5%
General and administrative expenses
29.9% of revenue
Adjusted operating margin
3.6%
Shareholder returns
approximately $8 million
Remaining share repurchase authorization
$137.3 million
Prysm iO scans
nearly 2 million
Prysm iO devices
more than 30,000
Subscription volume
up 5%
Subscribers to total customers
up 14%
LifePak sales
more than 10% year-over-year growth
Credit facility maturity
through 2031
Earnings Call Recording
Other Earnings Calls

Management

Mr. Steven J. Lund J.D.
Co-Founder & Executive Chairman of the Board
No Bio Available
Mr. Ryan S. Napierski
President, CEO & Director
No Bio Available
Mr. James D. Thomas
Executive VP, Chief Accounting Officer & CFO
No Bio Available
Dr. Joseph Y. Chang Ph.D.
Executive VP & Chief Scientific Officer
No Bio Available
Mr. Chayce David Clark
Executive VP & General Counsel
No Bio Available
Mr. Steve Keith Hatchett
Executive VP & Chief Product Officer
No Bio Available
Ms. Sandra N. Tillotson
Founder
No Bio Available
Mr. Joe Sueper
Senior VP & CTO
No Bio Available
Mr. Mark L. Adams
Chief Information Officer
No Bio Available

Contacts

Address
UTAH
Provo
75 W Center St
Contacts
+18013451000.0
www.nuskin.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett